AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
BWIN

The Baldwin Insurance Group Inc. Class A Common Stock (BWIN) fair value

Financial Services · Insurance Brokers · NASDAQ · United States
$31.96+0.22%
Market cap $4.5BNext earnings 2026-11-03Updated Oct 20, 2026
Add earnings to calendarGoogle
Our verdict
Trades 12% below our fair value
Price
$31.96
Model fair valueConfidence: low
about $36.38
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps and Analyst consensus.
ACCE opinionThe Baldwin Insurance Group Inc. Class A Common Stock (BWIN)
Fair value (2 models)
Not available
ACCE price target
$33.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Price used: $31.96 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus and Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
56
out of 100
Analysts
0% buy
8 covering
P/E
0.0x
forward 12.3x
1-year return
+30.9%
Dividend yield
0.00%

The Baldwin Insurance Group Inc. Class A Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

The Baldwin Insurance Group is an insurance brokerage that places commercial, personal and benefits coverage for clients, earning commissions and fees from carriers and policyholders, and it has grown revenue 30.1% over the period in our dataset, a pace few brokers match. The bull case rests on that growth coming through acquisitions and organic expansion in a fragmented market where scale buyers can keep consolidating smaller agencies. The near-term question is margin: operating margin of 2.0% against a 31.3% gross margin shows how much of the top line is absorbed by operating costs and integration spending, and a 12.3x forward P/E only looks cheap if that gap closes as acquired books mature. Return on equity is negative at -10.7%, and the company's trailing P/E is not meaningful, so the case depends on earnings turning positive rather than on the current profitability record. The stock scores 54/100 in our framework and sits outside major index memberships, which keeps it off the radar of passive flows and may leave it under-followed, but that cuts both ways. It merits a deeper look mainly to test whether operating leverage is real, which means checking acquisition integration costs and organic growth separately from deal-driven revenue.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Earnings collapsed year over year
    Earnings fell 90.0% YoY while revenue grew 30.1%, and the company posts a -4.7% net margin with a -10.7% ROE. Growth is not reaching the bottom line.
  • high
    Free cash flow deeply negative
    Free cash flow is -$68.9M against debt/equity of 2.95, so the business is consuming cash and leaning on leverage to fund operations.
  • moderate
    Insider selling without buying
    Insiders sold $4.28M across the last 10 disclosed transactions with no buys recorded, a one-directional signal worth weighing.

AI research notes

AI-assisted·How I use AIWritten Oct 19, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 30.1% over the past year, and the company has averaged 45.4% annual growth over five years.
  • At a forward P/E of 12.3x, the stock is priced below many growth peers, and analysts' mean target sits 1.6% above the current share price.
  • The company met expectations on its latest earnings, with earnings per share of 0.28 against 0.28 expected.
Why it could disappoint
  • The company lost money: net margin was -4.7% and return on equity was -10.7% in the latest filing.
  • Free cash flow over the last twelve months was -$69M, and the free cash flow yield is -1.5%, so the business is consuming cash.
  • Debt is 2.95 times equity, and the diluted share count rose 7.1% last year, diluting existing shareholders.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 3, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where BWIN's valuation models land
Price
$31.96
Model fair valueConfidence: low
about $36.38
Model
Fair value
Upside
Analyst consensus
Sales comps
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish0% buy · 8 covering analysts
● Strong buy 0● Buy 0● Hold 7● Sell 1● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+0.2%
1 month
+0.3%
3 months
+20.7%
6 months
+27.2%
YTD
+33.0%
1 year
+30.9%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
11 Oct 2026, 00:00 CESTACCE price target$33.00first publication$31.87
18 Aug 2026, 00:00 CESTFair value$20.66$20.41$30.19
28 Jul 2026, 00:00 CESTFair value$20.41$20.76$26.64
7 Jul 2026, 00:00 CESTFair value$20.76$20.46$28.41
30 Jun 2026, 00:00 CESTFair value$20.46first publication$25.96

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full BWIN page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth64Value38Quality25Momentum97Total56
Valuation
Trailing P/E
0.0x
Forward P/E
12.3x
PEG
no data
P/B
3.49x
EV / Revenue
4.0x
Book value/sh
$9.18
Enterprise value
$7.0B
Profitability
ROE
-10.7%
FCF yield
-1.54%
ROIC
-1.2%
Health and risk
Debt / equity
2.95
Dividend yield
0.00%
Beta
1.00

Price

+36.2% · 1Y

Ask anything about BWIN

Answered from The Baldwin Insurance Group Inc. Class A Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 0.0x0.0xhigh 124.9x
ROEbetter than 40% of peers
low -222%-11%high 31%
Div yieldbetter than 83% of peers
low 0.0%0.0%high 3.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
BWIN The Baldwin Insurance Group Inc. Class A Common Stock$31.96----10.7%2556
SDF.AX Steadfast Group LimitedA$5.81A$515% above24.2x12.4%7455
ARX Accelerant Holdings Class A Common Shares$19.76$2313% below--222.0%6075
CRVL CorVel Corp. Common Stock$83.88$37129% above37.4x30.7%7866
POLICYBZR.NS PB Fintech Limited₹1037.90--61.3x-7652
NP Neptune Insurance Holdings Inc. Class A Common Stock$28.72--124.9x0.0%5854
LIFE Ethos Technologies Inc. Class A Common Stock$43.53$17153% above--26.1%3858

Sector report card

Where BWIN ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 13, 2026
    Founder Shield Rebrands as The Baldwin Group
  • Business Wire•Sep 30, 2026
    MSI Brings Embedded Insurance and Compliance to Manufactured Housing Communities
  • PR Newswire•Sep 30, 2026
    Kanguro Insurance Partners with MSI to Automate Insurance Compliance for Multifamily Communities
5 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 16
Form 4Insider transactionPeriod 2026-10-14
View on SEC →
Oct 9
8-KCurrent reportPeriod 2026-10-09
View on SEC →
Oct 2
Form 4Insider transactionPeriod 2026-10-01
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR